Cargando…

Research advances in peptide‒drug conjugates

Peptide‒drug conjugates (PDCs) are drug delivery systems consisting of a drug covalently coupled to a multifunctional peptide via a cleavable linker. As an emerging prodrug strategy, PDCs not only preserve the function and bioactivity of the peptides but also release the drugs responsively with the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gong, Liming, Zhao, Heming, Liu, Yanhong, Wu, Hao, Liu, Chao, Chang, Shuangyan, Chen, Liqing, Jin, Mingji, Wang, Qiming, Gao, Zhonggao, Huang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501876/ https://www.ncbi.nlm.nih.gov/pubmed/37719380 http://dx.doi.org/10.1016/j.apsb.2023.02.013

Ejemplares similares

Development of Novel Paclitaxel-Loaded ZIF-8 Metal-Organic Framework Nanoparticles Modified with Peptide Dimers and an Evaluation of Its Inhibitory Effect against Prostate Cancer Cells
por: Zhao, Heming, et al.
Publicado: (2023)

Combined Biomimetic MOF-RVG15 Nanoformulation Efficient Over BBB for Effective Anti-Glioblastoma in Mice Model
por: Wu, Hao, et al.
Publicado: (2022)

Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides/proteins
por: Han, Ying, et al.
Publicado: (2019)

Triple Cross‐linked Dynamic Responsive Hydrogel Loaded with Selenium Nanoparticles for Modulating the Inflammatory Microenvironment via PI3K/Akt/NF‐κB and MAPK Signaling Pathways
por: Wang, Shuangqing, et al.
Publicado: (2023)

Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment
por: Kang, Lin, et al.
Publicado: (2015)

Biomimetic and temporal-controlled nanocarriers with ileum transporter targeting for achieving oral administration of chemotherapeutic drugs
por: Liu, Wei, et al.
Publicado: (2022)

Correction: Biomimetic and temporal-controlled nanocarriers with ileum transporter targeting for achieving oral administration of chemotherapeutic drugs
por: Liu, Wei, et al.
Publicado: (2022)

Development and Evaluation of a PSMA-Targeted Nanosystem Co-Packaging Docetaxel and Androgen Receptor siRNA for Castration-Resistant Prostate Cancer Treatment
por: Zhang, Yingying, et al.
Publicado: (2022)

Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice
por: Jin, Wenyu, et al.
Publicado: (2018)

Improving the anti-keloid outcomes through liposomes loading paclitaxel–cholesterol complexes
por: Wang, Mengjiao, et al.
Publicado: (2019)

Co-Delivery of Repurposing Itraconazole and VEGF siRNA by Composite Nanoparticulate System for Collaborative Anti-Angiogenesis and Anti-Tumor Efficacy against Breast Cancer
por: Jin, Mingji, et al.
Publicado: (2022)

Development of Mitomycin C-Loaded Nanoparticles Prepared Using the Micellar Assembly Driven by the Combined Effect of Hydrogen Bonding and π–π Stacking and Its Therapeutic Application in Bladder Cancer
por: Qi, Lingling, et al.
Publicado: (2021)

Systemic siRNA Delivery with a Dual pH-Responsive and Tumor-targeted Nanovector for Inhibiting Tumor Growth and Spontaneous Metastasis in Orthotopic Murine Model of Breast Carcinoma
por: Fan, Bo, et al.
Publicado: (2017)

Recent advances in drug delivery systems for targeting cancer stem cells
por: Duan, Hongxia, et al.
Publicado: (2021)

Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes
por: Jin, Mingji, et al.
Publicado: (2018)

The influence of the gut microbiota on the bioavailability of oral drugs
por: Zhang, Xintong, et al.
Publicado: (2021)

Smart Polymeric Nanoparticles with pH-Responsive and PEG-Detachable Properties (II): Co-Delivery of Paclitaxel and VEGF siRNA for Synergistic Breast Cancer Therapy in Mice
por: Jin, Mingji, et al.
Publicado: (2021)

Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis
por: Sun, Ping, et al.
Publicado: (2016)

Research Advances in Nucleic Acid Delivery System for Rheumatoid Arthritis Therapy
por: Zhang, Xintong, et al.
Publicado: (2023)

Versatile flexible micelles integrating mucosal penetration and intestinal targeting for effectively oral delivery of paclitaxel
por: Liu, Chao, et al.
Publicado: (2023)

LA67 Liposome-Loaded Thermo-Sensitive Hydrogel with Active Targeting for Efficient Treatment of Keloid via Peritumoral Injection
por: Wan, Hongshuang, et al.
Publicado: (2023)

Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies
por: Hoppenz, Paul, et al.
Publicado: (2020)

Docetaxel-Encapsulating Small-Sized Polymeric Micelles with Higher Permeability and Its Efficacy on the Orthotopic Transplantation Model of Pancreatic Ductal Adenocarcinoma
por: Li, Yunfei, et al.
Publicado: (2014)

Dendrimer-conjugated isotretinoin for controlled transdermal drug delivery
por: Zhao, Tianqi, et al.
Publicado: (2023)

Learn from antibody–drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy
por: Wu, Mo, et al.
Publicado: (2022)

Lysosomal-Cleavable Peptide Linkers in Antibody–Drug Conjugates
por: Balamkundu, Seetharamsing, et al.
Publicado: (2023)

Research Progress of Antibody–Drug Conjugate Therapy for Advanced Gastric Cancer
por: Wang, Na, et al.
Publicado: (2022)

Peptide–drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?
por: Fu, Chen, et al.
Publicado: (2023)

siRNA-loaded poly(histidine-arginine)(6)-modified chitosan nanoparticle with enhanced cell-penetrating and endosomal escape capacities for suppressing breast tumor metastasis
por: Sun, Ping, et al.
Publicado: (2017)

Molecular Engineering of Peptide–Drug Conjugates for Therapeutics
por: Fang, Yu, et al.
Publicado: (2022)

Peptide Drug Conjugates and Their Role in Cancer Therapy
por: Heh, Ethan, et al.
Publicado: (2023)

Phase I study of A166, an antibody‒drug conjugate in advanced HER2-expressing solid tumours
por: Zhang, Jian, et al.
Publicado: (2023)

Antibody-drug conjugates: recent advances in conjugation and linker chemistries
por: Tsuchikama, Kyoji, et al.
Publicado: (2016)

Small-sized polymeric micelles incorporating docetaxel suppress distant metastases in the clinically-relevant 4T1 mouse breast cancer model
por: Li, Yunfei, et al.
Publicado: (2014)

Improved Antitumor Outcomes for Colon Cancer Using Nanomicelles Loaded with the Novel Antitumor Agent LA67
por: Cui, Minhu, et al.
Publicado: (2020)

Antibody–drug conjugates: Recent advances in linker chemistry
por: Su, Zheng, et al.
Publicado: (2021)

Antibody–Drug Conjugate that Exhibits Synergistic Cytotoxicity with an Endosome–Disruptive Peptide
por: Knewtson, Kelsey E., et al.
Publicado: (2019)

NGR-peptide−drug conjugates with dual targeting properties
por: Enyedi, Kata Nóra, et al.
Publicado: (2017)

Targeting BCMA in Multiple Myeloma: Advances in Antibody-Drug Conjugate Therapy
por: Xing, Lijie, et al.
Publicado: (2023)

Advances and Limitations of Antibody Drug Conjugates for Cancer
por: Mckertish, Candice Maria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t1ug2a6p593hle8pcbomebk7je